FLUDARA

国: イスラエル

言語: 英語

ソース: Ministry of Health

即購入

有効成分:

FLUDARABINE PHOSPHATE 50 MG/VIAL

から入手可能:

SANOFI - AVENTIS ISRAEL LTD

ATCコード:

L01BB05

医薬品形態:

POWDER FOR SOLUTION FOR INJ/INF

投与経路:

I.V

製:

GENZYME EUROPE B.V., NETHERLANDS

治療群:

FLUDARABINE

適応症:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

承認日:

2009-02-01

この製品に関連するアラートを検索

ドキュメントの履歴を表示する